v3.26.1
Parent-Only Financials - Schedule of Condensed Statements of Cash Flows (Details) - USD ($)
 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows from Operating Activities:    
Net loss $ (5,371,504) $ (3,680,812)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of intangible assets 75,000 75,000
Stock compensation expense 250,000
Gain from debt forgiveness (42,581)
Gain from voluntary waiver of compensation by related parties (170,000)
Excess of warrant fair value over offering proceeds 2,896,455
Offering costs allocable to derivative liabilities 12,575
Change in operating assets and liabilities    
Prepayments, receivables and other current assets 335,428 16,654
Due from a related party 60,919 69,288
Accrued expenses and other liabilities (731,618) 229,642
Net Cash (Used in) Provided by Operating Activities (1,601,561) 500,303
Cash Flows from Investing Activities:    
Loan to a related party (229,469)
Net Cash Used in Investing Activities (193,939) (464,778)
Cash Flows from Financing Activities:    
Net proceeds from exercise of November 2021 Private Placement Warrants 341,251
Net proceeds from issuance of common stock in PIPE Offering 659,992
Net proceeds from registered direct offering of common stock and pre-funded warrants, and concurrent private placement of warrants 2,828,725
Repayment from subsidiaries (269,365) (11,940)
Net Cash Provided by (Used in) Financing Activities 4,419,010 (123,720)
Cash, cash equivalents and restricted cash, beginning of the year 833,577 794,636
Cash, cash equivalents and restricted cash, end of the year 3,599,821 833,577
Parent Company [Member]    
Cash Flows from Operating Activities:    
Net loss (5,270,200) (3,725,305)
Adjustments to reconcile net loss to net cash used in operating activities:    
Equity of loss of subsidiaries 1,023,390 2,951,525
Amortization of intangible assets 75,000 75,000
Stock compensation expense 250,000
Gain from debt forgiveness (42,581)
Gain from voluntary waiver of compensation by related parties (170,000)
Excess of warrant fair value over offering proceeds 2,896,455
Offering costs allocable to derivative liabilities 12,575
Change in fair value of derivative liabilities (202,959) (204,242)
Change in operating assets and liabilities    
Prepayments, receivables and other current assets (199,143) 37,124
Due from a related party 75,000
Due to a related party 78,398
Accrued expenses and other liabilities (684,105) 201,761
Net Cash (Used in) Provided by Operating Activities (2,158,170) (664,137)
Cash Flows from Investing Activities:    
Loan to a related party (229,469)
Loan to subsidiaries (1,579,028)
Net Cash Used in Investing Activities (1,808,497)
Cash Flows from Financing Activities:    
Net proceeds from exercise of November 2021 Private Placement Warrants 341,251
Net proceeds from issuance of common stock in PIPE Offering 659,992
Net proceeds from registered direct offering of common stock and pre-funded warrants, and concurrent private placement of warrants 2,828,725
Repayment from subsidiaries 569,239
Borrowings from related parties 137,500 74,773
Net Cash Provided by (Used in) Financing Activities 3,967,468 644,012
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation, Total 801 (20,125)
Cash, cash equivalents and restricted cash, beginning of the year 999 21,124
Cash, cash equivalents and restricted cash, end of the year $ 1,800 $ 999